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Resumo
O processo de desenvolvimento de drogas é altamente condicionado
pela qualidade dos modelos com os quais se realiza a seleção dos
primeiros compostos. Este trabalho procurou avaliar vários metodolo-
gias e descobrir qual a melhor abordagem para a construção de mod-
elos de QSAR (relação quantitativa estrutura-propriedade/atividade)
usando um conjunto grande de problemas.
Usando um banco de dados de modelação de problemas desenvolvidos
no projeto de pesquisa MIMED, 500 conjunto de dados foram extraí-
dos de forma a serem usados para a construção de modelos QSAR.
Quarenta metodologias diferentes, resultantes na combinação de qua-
tro algoritmos de machine learning, dois fingerprints e cinco valores de
bits, foram usados para fazer os modelos. Com o uso destas metodolo-
gias forma criados 18000 modelos, dos quais após análise surgiu a
abordagem que melhor generaliza os modelos. Esta é a combinação
dos seguintes parâmetros: random forest without maximum depth
com Extended-Connectivity Fingerprints de raio 2 usando 2048 bits.
Esta abordagem após validação construiu modelos com valores RMSE
(Root Mean Square Error) de 0.17 e valores PVE (Proportion of Vari-
ance Explained) de 0.63.
Por fim, procurou-se otimizar o processo de construção de modelos
QSAR com a utilização da técnica de feature selection. Daqui resultou
uma redução no conjunto de variáveis utilizadas pelo algoritmo resul-
tando na construção de modelos mais robustos, mantendo o mesmo
desempenho, RMSE de 0.17 e PVE de 0.59. Por fim a metodolo-
gia escolhida foi comparada com uma abordagem construída usando
KNIME de forma a ter a perceção do fitness dos modelos construídos.
Keywords: Machine Learning, Chemioinformatics, Fingerprints, apren-
dização automática, seleção de variáveis, Python, SkLearn, QSAR

Abstract
The drug development process is highly conditioned by the quality of
the mathematical models with which the first compounds are selected.
In this work, we tried to evaluate various methods and find out which
are the best parameters for building Quantitative Structure-Activity
Relationship (QSAR) models using a large set of problems.
Using a database of modelling problems developed within the research
project MIMED, 500 datasets were extracted to be used for building
QSAR models. Forty different methodologies, resulting from the com-
bination of four machine learning algorithms, two fingerprints and five
bit values, were used to make the models. Using these methodologies,
18000 models were created, from which after analysis came the ap-
proach that best generalizes the models. This is the combination
of the following parameters: random forest without maximum depth
with Extended-Connectivity Fingerprints of radius 2 using 2048 bits.
This approach after validation builds models with Root Mean Square
Error (RMSE) values of 0.17 and Proportion of Variance Explained
(PVE) values of 0.63.
After the choice of the methodology, we tried to optimize the process
of building QSAR models using the feature selection technique. This
resulted in a reduction in the set of variables used by the algorithm
resulting in the construction of more robust models, maintaining the
same performance, RMSE of 0.17 and PVE of 0.59. Finally, the chosen
methodology was compared with an approach built using KNIME to
have the perception of the fitness of the built models.
Keywords: Machine Learning, Chemioinformatics, Automatic Learn-
ing, Fingerprints, Selection of Variables, Python, SkLearn, QSAR

Resumo Alargado
O desenvolvimento de drogas novas é um processo muito complexo,
demoroso, que consome muito dinheiro e que muitas vezes resulta no
desenvolvimento de um produto que na reta final de aprovação falha
a cumprir os requisitos necessários. Como tal, qualquer hipótese que
haja para reduzir o tempo, o preço, a complexidade e aumentar o
sucesso do processo é importante para o estudo. O desenvolvimento de
drogas computacionalmente assistido apresenta-se como um método
eficiente e capaz de contribuir para o auxílio e resolução destes prob-
lemas. Comparado às técnicas tradicionais de descoberta e desen-
volvimento de novas drogas, o desenvolvimento de drogas computa-
cionalmente assistido tira não só proveito de tecnologias referentes
a aprendizagem automática como também de conhecimentos biológi-
cos prévios e grandes quantidades de informação para uma seleção
rápida e precisa de moléculas, com propriedades farmacológicas de
interesse para o problema em estudo, para posterior análise em lab-
oratório. Este desenvolvimento pode ser baseado em dois ramos, o
design de drogas baseado nas estruturas (SBDD) e o design de dro-
gas baseado nos ligandos (LBDD). A primeira etapa deste processo,
denominada de descoberta de drogas, é responsável pela escolha de
moléculas com propriedades farmacêuticas com potencial terapêutico
para tratar uma determinada doença. Com o auxílio de métodos
de aprendizagem automática, técnicas de data-mining e do uso da
relação quantitativa estrutura-propriedade/atividade (QSAR), é pos-
sível construir modelos que consigam prever as propriedades que uma
determinada molécula tem antes desta entrar em fase de testes labora-
toriais. Tal deve-se ao uso de métodos QSAR para construir modelos
capazes de prever as propriedades farmacológicas de uma molécula
através da sua estrutura química. Durante a construção dos mod-
elos QSAR existe alguns aspetos que se devem ter em conta, como
a curadoria dos conjuntos de dados, a escolha do tipo de algoritmo
de aprendizagem automática a ser usado e a forma de representar as
estruturas químicas dos conjuntos de dados (fingerprints). Este tra-
balho tem como objetivo a seleção da melhor metodologia, dentro de
um conjunto de 40 abordagens, capaz de construir modelos QSAR a
partir de um conjunto grande de problemas, que dê resultados con-
sistentemente bons e robustos. Para tal, recorreu-se à base de dados
do projeto MIMED (Mining the Molecular Metric Space for Drug De-
sign), da qual se extraiu 500 conjuntos de dados que representam os
problemas a serem modelados. Estes sofreram múltiplos processos de
manipulação e transformação, através de um script desenvolvido, de
forma a poderem ser usados para a criação de modelos preditivos.
Primeiro , estes conjuntos sofreram um processo de limpeza, levando
a uma redução do tamanho dos dados de cerca de 49%. De seguida,
as atividades de cada molécula dentro do conjunto de dados sofr-
eram uma normalização dos seus valores para um intervalo de 0 a 1.
Esta normalização divide-se em dois passos: a passagem de todas as
unidades das atividades registadas para nM e a consequente utiliza-
ção de uma função logarítmica para transformar estas atividades no
intervalo acima referido. Dentro de cada conjunto de dados existe um
aglomerado de informação, não sendo toda ela necessária para o pro-
cesso de criação de modelos. Tendo isto em conta apenas os campos
contendo o ChEMBL ID, a atividade normalizada e o formato Sim-
plified molecular-input (SMILES) de cada molécula foram guardados
num ficheiro novo, sendo que estas três informações são as necessárias
para criar modelos, ficando assim o novo ficheiro mais compreensível e
limpo. Tendo os conjuntos de dados sido limpos, procede-se ao cálculo
das fingerprints com o auxílio da biblioteca SkLearn. Estas são uma
forma de representação da molécula em formato numérico, capaz de
ser usado pelo algoritmo para construir os modelos de previsão. São
usados dois tipos de fingerprints neste trabalho, o extended circular
fingerprint de raio 2 (ECFP4) e o extended circular fingerprint de
raio 3 (ECFP6), em que a grande diferença reside no número de áto-
mos que está a ser abrangido Procede-se à construção dos modelos
QSAR. Cada conjunto de dados sofreu uma partição aleatória da sua
informação através de uma função, em que 75% dos dados vão para
o conjunto de treino, usado para treinar o modelo com o auxílio da
técnica de N-Cross Fold Validation, e 25% para o conjunto de IVS,
usado para validar o modelo. Estes conjuntos de treino e de IVS são
usados por 40 abordagens distintas que se baseiam na combinação
de três parâmetros: 4 algoritmos da aprendizagem automática, 2 fin-
gerprints e 5 números de bits. Os modelos são avaliados consoante
duas variáveis estatísticas, o Root Mean Square Error (RMSE) que
indica a qualidade do modelo construído refletindo a diferença entre
a “verdade” e o que o modelo previu (quanto menor o valor de RMSE
melhor) e a Proporção de Variância Explicada (PVE) que indica o
poder de previsão do modelo (quando maior o valor de PVE melhor).
Foi estabelecido um limite para o qual todos os modelos têm de obede-
cer para serem considerados modelos preditivos, RMSE < 0.3 e PVE
> 0.3. Os modelos que obtivessem valores acima (para o RMSE) ou
abaixo (para o PVE) não eram considerados. Tendo o threshold em
conta durante os primeiros testes, 50 conjuntos de dados provaram
ser difíceis de modelar, pelo que foram retirados do conjunto a ser
modelado ficando reduzido a 450.
O uso das 40 metodologias diferentes nos 450 alvos a modelar resul-
tou na construção de 18000 modelos QSAR. Após a análise dos dados
obtidos com recurso à realização do teste de ranking Friedman, que
atribui ranks aos modelos criados, conclui-se que a melhor abordagem
a ser usada dentro do leque de metodologias usadas, é a combinação
dos parâmetros: algoritmo “random forest without maximum depth”
acoplado aos ECFP4 com 2048 bits. O uso desta abordagem para os
450 problemas originou uma mediana para o RMSE de 0.17 e para o
PVE de 0.63. Com a melhor abordagem selecionada procurou-se au-
mentar a performance da construção de modelos. Para tal, usou-se a
técnica de “feature selection”, que consiste na escolha das variáveis que
mais contribuem para a construção dos modelos, não usando para a
construção do modelo as restantes. Ao utilizar este método aumenta-
se a robustez dos modelos gerados, diminuindo-se a hipótese de “over-
fitting”. Com o uso do “feature selection”, corre-se o risco da perda de
informação visto que se está a eliminar variáveis usadas na construção
do modelo. No entanto, os resultados obtidos demonstram que tal não
aconteceu uma vez que o RMSE obtido tem um valor de 0.17 e o PVE
um valor de 0.59, muito próximos dos valores obtidos sem a realização
do “feature selection”. Finalmente realizou-se uma comparação direta
da metodologia escolhida neste trabalho, com uma metodologia de-
senvolvida noutro sistema, nomeadamente, no KNIME. O objetivo
deste passo é perceber como os resultados dos modelos desenvolvi-
dos neste trabalho se comportam comparados com os resultados de
modelos desenvolvidos usando outra abordagem. Para tal, dez alvos
foram aleatoriamente escolhidos e usados por ambas as pipelines para
construir os modelos usando os parâmetros escolhidos neste trabalho.
Dez modelos foram feitos com a metodologia de eleição e vinte foram
feitos usando a abordagem do KNIME, sendo que destes vinte , dez
usam um tipo de fingerprints (Kausar_1) e os outros dez usam finger-
prints diferentes (Kausar_2). Conclui-se que a abordagem Kausar_1
é a que produz modelos com melhores resultados, no entanto real-
izando o teste de Friedman não existe diferença estatística suficiente
para afirmar que uma abordagem prevalece em relação às outras. É
de notar que a metodologia escolhida neste trabalho, quando com-
parada com as duas abordagens usadas em KNIME, produz modelos
num menor tempo. Futuramente, o ideal seria, com a abordagem sele-
cionada, realizar um teste funcional para um problema em especifico,
ou seja, construir modelos QSAR com a metodologia selecionada de
modo a selecionar moleculas capazes de resolver o problema e testá-
las in vitro. Seria também interessante experimentar novas técnicas
de construção de fingerprints, e também algoritmos de aprendizagem
automática de forma a englobar mais problemas, mantendo a robustez
e performance já existentes.
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Chapter 1
Introduction
Drug development is an extremely expensive and highly complex process, which
results in being very prone to failure.
Figure 1.1: Relationship between the increasing in the number of new molecular
entities (NME) approvels and the money spent in Research and Development
(Berger et al., 2013).
Multidisciplinary drug development teams have always been tasked with solv-
ing problems associated with this procedure (for example, the high amount of
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money and resources spent) and have tried to find new methods that upgrade
the quality of the drugs being developed as well as enhance the diagnoses of the
problems.
This process is typically centered in 4 phases, from compound selection after
knowing the nature of the problems to approval of the drug for human consump-
tion.
As shown in the figure 1.2, these stages are called: Drug Discovery, Pre-
Clinical development, Clinical development and Regulatory approval (FDA, 2019).
Figure 1.2: Drug development timeline (Phillip, 2018)
Drug Discovery: First, a disease is selected to be further investigated in or-
der to find the mechanisms from which it’s regulated. Through progress of fields
such as biochemistry, new mechanisms of molecular regulation are discovered and
with said discoveries, knowledge is obtained on how these diseases work. By these
processes, molecular targets can be marked to be further studied and to identify
their correlation with the disease and how said molecule influences the problem
2
when blocked or activated. Several laboratory tests are conducted in order to
ensure that the elected targets are connected with the disease selected. Once
validated, this step unlocks a scientist’s ability to gather multiple chemical struc-
tures entities that probably have some therapy potential to treat the designated
problem. After some short testing of the picked molecules, that list is shortened
to a smaller number of compounds that looks promising. Subsequently this group
of compounds is selected and more experiments are conducted in order to acquire
information about them, with the intention of removing compounds who aren’t
fit for drug making.
Pre-Clinical Development: Tests in vitro and/or in vivo are made in order
to obtain information about the compounds, mainly about the minimum dosing
required for the compound take effect. the potency said compound, and further-
more to test the necessary dosage for it to be toxic to the patient. In this stage
a large group of compounds are eliminated from the list of potential candidates
to make a drug.
Clinical Development: In vitro and in vivo tests are capable of revealing
a lot of information about the drug at issue, but it can’t tell to the researchers
how it will interact with the human body. To discover this particular issue,
clinical tests are run in volunteers in order to understand how the drug reacts
when put in direct contact with the human body. These tests are divided in 3
phases each and every one of them different, so researchers can ensure the drug
developed is safe for human usage. Regarding the first phase, twenty to a hundred
healthy candidates are hand-picked, to find out if the information, obtained in
the pre-clinic tests, is either accurate or not (about 70% of tested drugs advance
into the following stage). In the second phase, about 100 to 500 candidates
with the disease, are introduced for the first time, to investigate the efficiency
and the secondary effects of the drug (Only 33% of the tests performed in this
phase progress to the succeeding one. The third and final phase is where the
safety, efficiency and secondary reactions of the drug are monitored with 1000-
5000 candidates that possess the disease (25-30% of the drugs tested in this phase
advance to the next stage).
Regulatory Approval: If a drug passes all the tests, the company respon-
sible for the development can fill an application to market the drug.
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1.1 Motivation
The main incentive that led to producing this work was to find out if there’s a
consistently good method to return a robust model with good results regardless
of the situation to model, while having a very large set of public data sets, based
on two criteria, which are: being human proteins and also the size of the data
sets being large enough.
1.2 Objectives
The main purpose of this dissertation is to test and evaluate if there’s any method-
ology within a set of methodologies that’s consistently better than the others to
model a large set of problems in series.
Hypothesis: There is a methodology for parameterization and adjustment of
machine learning models that can consistently yield good results regardless
of the QSAR (Quantitative structure–activity relationship) problem to be
considered.
1.3 Contributions
With the elaboration of this work, the main contributions resulting from this are
the following:
Contribution 1: Selection of a methodology to build QSAR models using a big
number of problems.
Contribution 2: Implementation of a QSAR method in Python with the help
of scikit-learn.
Contribution 3: Set of parameters for building QSAR models with good results
for a big number of targets;
4
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1.4 Overview
The present document is organized by chapters containing six of them. The first
chapter is a brief introduction to the problem as well as the history behind it,
followed by this project’s purpose and contributions to the scientific community.
The second chapter talks about the state of the art that will be used in this
work, with more detailed information on the tools that are used, followed by the
third chapter, the explanation of methods and data used to produce the results.
In the fourth chapter, the results obtained during the investigation are dis-
played and comments are made regarding their significance followed, by the fifth
chapter, the discussion of the obtained results and what they mean to the prob-
lem.
Finally, in the sixth chapter, we spoke briefly about the outcome of the work
done.
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Chapter 2
Background
2.1 Computer Aided Drug Design
Like previously discussed, discovery of new molecules with pharmaceutical pro-
prieties to known health problems is getting very expensive and time consuming.
In order to tackle the problem computer aided drug discovery (CADD) was devel-
oped and nowadays more and more researchers tend to use this method, not only
saving money, time and resources but because novel compounds can be tested
in silico to verify their biological activity (Nantasenamat et al., 2010). Doing
this step can save a lot of money and time in later stages of drug design, where
tests in vivo are needed and knowing the pre-result beforehand can be time and
money saving (Camilo et al., 2014). This method is preferred in comparation
to alternative approaches like virtual high throughput screening (HTS) because,
in contrary of other methods, CADD can predict new compounds that are bio-
logically effective against a certain molecular target of study with higher success
rates (Lionta et al., 2014).
CADD have two different approaches, structure-based and ligand-based and
one of those approaches needs to be chosen before doing the virtual screening
of a chemical database in order to discover a new compound (Macalino et al.,
2015). Its also known that previous biological knowledge of the molecular target
structure or of the ligands bioactivities is a major factor in the decision of which
of both approaches should be chosen for the research.
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Figure 2.1: Process of the CADD Macalino et al. (2015).
2.1.1 Structure based drug design (SBDD)
SBDD is a method that uses ligand and target structures to perform structural
analysis to deduce how the ligand interacts with the target. By using this ap-
proach, one can identify which ligand is best to inhibit/activate the target in
question. According to Houston & Walkinshaw (2012) there are two major steps
to perform a struture-based prediction: first is to sorting out which is the correct
docking site for the ligand, in other words, the orientation and conformation that
both the ligand and the target must have in order to interact. Second is to predict
binding affinities close to experimental observations. The accuracy of the final
score is dependent of the accuracy of the first step (Anderson, 2003).
Not all cases can use only one score algorithm like showed in Warren et al.
(2006), As has been shown, the use of only one algorithm may result in certain
cases in producing deceptive predictions about structural analysis between ligands
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and targets. It is shown in Houston & Walkinshaw (2012) that combining at
least two scoring algorithms, a method named consensus scoring, can increase
the correctness of docked ligands up to 18%.
As seen so far docking is a crucial step to achieve success in SBDD, but its also
a hard task to do, mainly because proteins don’t have only one conformation, they
have numerous conformations making the docking score process a difficult task
to be performed. To make and explore the different conformations, SBDD uses
software to predict the orientation of the ligand and the target (Grinter & Zou,
2014). Ligands are then treated like physical entities and different conformation
tested, scored and ranked, through scoring functions with the objective to find the
best position and orientation of the ligand, that binds with the target (Schneider
& Böhm, 2002).
This models can be done, like said above, with a great variety of software avail-
able like, DOCK, AutoDOCK, LUDI, FlexX, GOLD and many others (Grinter
& Zou, 2014; Schneider & Böhm, 2002).
Program
Flexible
Protein
Flexible
Ligand
Description
DOCK No Yes
Docks either small molecules
or fragments, includes solvent effects.
FlexX No Yes Incremental Construction
AUTODOCK Yes Yes
Uses averaged interaction energy grid
to account for receptor conformations
and simulated annealing
for ligand conformations
LUDI No Yes Docks and scores fragments
Table 2.1: Various algorithms and their characteristics.
2.1.2 Ligand-based drug design (LBDD)
LBDD is based in analysis of structural and/or activity, biological or chemical
properties, data for compounds that have been tested in an assay against a bio-
logical target (Macalino et al., 2015).
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The logic behind this affirmation, is that using several active ligands of the
molecular target it can infer not only its structure but also its chemical and/or
molecular properties. It’s done using the structural similarity of the molecules,
which says that if molecules have similar structures, they will have similar biolog-
ical activity. On this study it’s used public data sets big enough to be modulated,
containing ligands often used against a molecular target. Due to this fact, the
LBDD category of CADD is the one that will be used.
This approach have a few techniques to find the new candidates, like the
Pharmacophore modeling and the highly popular Quantitative Structure-Activity
Relationship (QSAR).
2.1.2.1 Quantitative Structure-Activity Relationship (QSAR)
QSAR modeling is a technique that relies in the application of statistical or
machine learning methods to predict the activity of compounds. It can be char-
acterized by a collection of defined protocols and procedures that enable the
application of this technique to explore collections of biologically active chemical
compounds (Tropsha, 2010).
The goal of QSAR is to establish a connection between descriptor values and
their biological activity. QSAR Modeling approaches imply, directly or indirectly,
a simple similarity principle. The properties of a molecule are directly related to
its structure, hence if the structure of a molecule is determined upon comparison
with other similar compounds it’s possible to infer its chemical properties (Trop-
sha, 2010). The objective of using QSAR is to generate statistical models able to
predict biological properties of novel compounds (Macalino et al., 2015) and to
accomplish this a set of steps has to be performed.
The overall workflow can be described by the following steps (Kausar & Falcao,
2018; Tropsha, 2010):
• Curated the data set, guaranteeing the standardization of biological ac-
tivity values. Performing this process ensures data quality for subsequent
calculations;
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• Proper splitting of data in the training set and independent validation score
set (IVS). The training set is therefore divided through the N-Cross Valida-
tion technique into multiple training and test sets, during the modulation
stage, being these sets used to develop the models and validate them at an
early stage. IVS is later used once to externally validate the model;
• During the modeling phase, multiple QSAR techniques based on the com-
bination of various descriptors and machine learning algorithms, are used
to build predictive models. These are evaluated by statistics that can be
analyzed to give information about the acceptability of the constructed
model;
• External validation of models using the IVS set is a critical step in the
QSAR method. It’s used to assure that the results are unbiased, to have
the perception of the quality of the prediction models built.
Figure 2.2: QSAR Workflow (Tropsha, 2010).
The ultimate goal of QSAR is to return a model with good predictive power,
when applied to experimental validation, can return positive results in predicting
the selection of chemical compounds (Tropsha, 2010).
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There are a lot of different approaches for QSAR. Comparative Molecular
Field Analysis (CoMFA) is a highly successful approach that is frequently em-
ployed. It uses the representation of ligand molecules, by their steric and elec-
trostic fields, which by data analysis using cross-validation can predict the like-
lihood of having similar biological activities (ASIKAINEN et al., 2005; Cramer
et al., 1988). Generating Optimal Linear PLS Estimations (GOLPE) is another
approach that was born of the need of selecting the most important variables to
making a more precise PLS model. The objetive is to find the best set of variables
able to make the best predictive PLS model (Baroni et al., 1993).
2.1.2.2 Pharmacophore modeling
The main goal for a pharmacophore model is to predict if a set of ligands are
active or inactive for a given protein target, gives us as an output a list of active
ligands. The concept of the pharmacophore model has been redefined over the
last years and nowadays it can be defined as a model that describes the common
properties that a group of ligands needs to have to bind to a specific receptor.
This can be verified when the 3D arrangements of molecules are similar, lead-
ing to the inference that molecules with similar 3D arrangements have similar
biological activities/chemical properties. Following the latest reasoning, this ap-
proach has the principle that if multiple molecules bind to the same receptor to
block/activate a protein, they will share similar chemical properties (Vuorinen &
Schuster, 2015).
There are a different set of ligand-based tools available to anyone who wants
to work with this type of model, for example, LigandScout, Discovery Studio,
MOE, PHASE and many others (Vuorinen & Schuster, 2015).
2.2 Digital Molecular Representation
When representing molecules digitally, it is extremely important to use methods
capable of differentiating similar compounds when they are compared, as the
slightest difference between a pair of atoms can result in a large change in the
chemical/biological properties of the molecule.
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When representing molecules digitally two major concerns arise in relation
to it, the representation and comparison of the molecules. Digitally representing
molecules is a major challenge, mainly because they can have many different
properties, structures, and sizes. It is important to realize that it is not always
possible to transform the molecule as it is, leading to the loss of information
during the transformation process.
Besides this, there is another problem, the choice of the method of repre-
sentation of the molecule. There is a diverse range of representations available,
for example, the IUPAC International Chemical Identifier (InChI) and the Sim-
plified Molecular Input Line Entry System (SMILES). Even if the method of
representation chosen is the most suitable, one still has to choose the method of
comparison. Each case is different and because of this, there is no overall com-
parison method that works with all cases in general. Currently, there are two
major groups where this comparison method can be fit: Molecular Descriptors
and Molecular Fingerprint.
2.2.1 Molecular Descriptors
As discussed previously, to process the chemical information of a given molecule
through a computerized way like QSAR, there is a need to represent this in-
formation in a format that is possible to quantify its characteristics. Molecular
descriptors are a result of a logical and mathematical procedure where the repre-
sentation of chemical information of a given molecule is transformed into numeric
values represented by vectors (Grisoni et al., 2018).
Depending on the type chosen for descriptors building, vectors can be differ-
entiated and classified through dimensions. Nowadays exist 5 classes of molecular
descriptors (0D, 1D, 2D, 3D, and 4D), each one more complex than the previous
therefore containing more information about the molecule. The type of class cho-
sen depends on the type of work to be developed because different problems holds
different information about the target (Oprea, 2002). The first class (0D) con-
tains information about simple characteristics like molecular weight, the second
class (1D) represents fingerprints of the molecule or, in another words, fragments
of the molecule, the third class (2D) represents the disposition of the molecule
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in space in terms of atoms and their type, the fourth class (3D) represents the
geometrical representation, the descriptor is created from the spatial (x, y, z)
coordinates, of the 2D class, and finally, the fifth class (4D) represents the geo-
metrical representation of the molecule (like the class 3D) but by introducing the
flexibility factor, mimicking the ability of the molecule to change shape. (Grisoni
et al., 2018).
Classes of molecular descriptors aim to mimic the behavior of the molecules.
This way researchers are able to understand the way it interacts with other
molecules, their properties, and biological activities before actually doing the
laboratory experiments.
The developed work uses 2D-molecular descriptors since they derived from
algorithms applied to a topological representation.
2.2.2 Molecular fingerprints
Molecular fingerprints are a way of encoding the structure representation/chem-
ical information of compounds. As well as molecular descriptors, molecular fin-
gerprints are one of the most important parameters in virtual screening studies.
This parameter is critical in predicting molecules in QSAR methods and the
wrong choice of fingerprints can result in compromising the prediction model,
causing the prediction results of the prediction model to be erroneous since the
model has learned wrong information through the descriptors.
Figure 2.3: Various algorithms and their characteristics (Gortari et al., 2017).
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Fingerprints technique is built upon two characteristics, hashed and circular,
and each add different information to the final result. Hashed is a bit string, that
can have values between 0 and 1. When a bit is encoded with the value = 0 it
means that there is in a given position of the molecule, an absence of a certain
feature. On the contrary, when bit has the value = 1, it means that the feature is
present in the position (Gortari et al., 2017). The circular characteristic evaluates
the neighborhood of each atom with a defined radius. The radius is the parameter
that describes the distance to be evaluated, meaning that if a radius of 1 is chosen,
all the adjacent atoms to the atom being evaluated are considered to the final
score, if the radius is 2, all the atoms adjacent to the atom being evaluated are
considered as well as all the atoms that have a bond with the atoms adjacent to
the atom in study. The logic for other numbers of radius follows the same logic.
Figure 2.4: Representation of the parameter radius in the process of making a
fingerprint (Rogers & Hahn, 2010).
A variant of the Morgan algorithm (Morgan, 1965) (a method used for identi-
fying when two molecules, with different atom numberings, are the same), called
Extended-Connectivity FingerPrints (ECFP) which is a combination of the Mor-
gan algorithm with alternative methods of atom identifiers and performance tech-
niques (Rogers & Hahn, 2010). ECFP is generated quickly, has a big range of
applications, it has features very important for analyzing molecular activity and
is a highly effective representation of the 2D molecular descriptors (topological
representation of structural information).
When provided with a radius and a number of bits, it gives a bit vector with
information about the chemical structure of a molecule. To approximate ECFP ,
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the Morgan fingerprints were deployed from RDKit using default settings and an
appropriate radius. Two versions were chosen for this study, the ECFP4, and the
ECFP6. ECFP4, as explained used the Morgan fingerprint where the parameter
that controls the number of iterations, the radius, is set with a value of 2 and
ECFP6 the value used for the radius is set at 3. Both these ECFPs are tested in
this methodology (Rogers & Hahn, 2010).
2.3 Supervised Machine Learning
Machine learning is the scientific study of algorithms and statistical models that
perform specific tasks without the implicit indication of instructions. These mod-
els are built from a training set, from which the model distinguish the patterns
and make inferences. In a final phase, the machine learning model receives a IVS,
whose objective is to understand the quality of the model. There are two types of
tasks: supervised and unsupervised, and with these different types of algorithms
associated with them. Supervised machine learning uses function, like the one
shown in equation 2.1, this method fits a given set of parameters, f, (differ con-
sonant the algorithm used) that predicts a response variable, yˆ, from a feature
vector, x.
yˆ = f(X) (2.1)
It’s really important to note that the output of the task always depends on the
type of supervised machine learning that is used by the function. There are two
types of supervised machine learning: Classification, where the response variable
is discrete and Regression, where the response variable is continuous (numeric).
A supervised machine learning algorithm constructs a model using labeled
observations from which it teaches the model how to analyze the data and after-
wards, when the model receives a test set, it can assign each new entry to a class
or predict a number1. Each supervised machine learning method has different
1https://blogs.nvidia.com/blog/2018/08/02/supervised-unsupervised-learning/, last ac-
ceded on 30 May 2019
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ways of evaluation. For example, the Classification method uses a confusion ma-
trix to be evaluated and the Regression method uses the Root Mean Square Error
(RMSE) (Schrider, 2018; Teixeira et al., 2013) and the Proportion of Variance
Explained (PVE) (Teixeira et al., 2013). RMSE is a statistical variable that mea-
sures the observed difference between what values are predicted by a model and
the actual values observed, allowing the qualification of the fit between the data
and the model, showing the error of distribution (Kausar & Falcao, 2019; Teix-
eira et al., 2013). RMSE is calculated using the module SKLearn. The RMSE
formula is the following:
RMSE =
√√√√ 1
N
N∑
i=1
(yˆi − yi)2 (2.2)
Where yˆi is the estimation for the dependent variable yi and N is the number
of predictions. The best models will have low value of RMSE, meaning that what
the model predicted in comparison with what the value is, is very close.
The PVE measures the proportion to which the model accounts for the vari-
ation of a given data set. For the perfect regression model, the percentage of
variance explained is 100% when the model has 100% accuracy. When the PVE
decreases it means that the estimation power of the model also decreases. For
example, if the reaches zero the model has no predictive power. Just like RMSE,
PVE is calculated using the SKLearn module. PVE is calculated using the fol-
lowing formula:
PV E = 1− MSE
V AR
(2.3)
Where MSE stands for mean square error which is the difference between
measured and predicted biological activity values, and VAR for variance, which
is the difference between measured biological activity values and the average of
all compound activities within the dataset.
There are other forms of evaluating the fitness of the model that was trained
using supervised machine learning, but the most common are the ones described
above.
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Normally associated with the classification method there are algorithms like K
Nearest Neighbour, Logistic Regression and Support Vector Machines. With the
regression method, there are Linear regression, Regression Forest and Support
Vector Machine - Regression.
2.3.1 Linear Models
Linear models use the technique of linear regression that is a modeling of the
relationship between dependent variables and independent variables, assuming
a linear relationship between them. In the current case of study, those are the
molecular fingerprints and the biological activity of molecules respectively. The
use of linear models has the objective of understanding if molecular fingerprints
have a positive or negative effect on the characteristics of interest (Y) when con-
structing the predictive model. In other words, whether fingerprints contribute
with new knowledge to model learning or not. It is called multiple linear regres-
sion because it isn’t only one variable being modeled, instead, multiple variables
are used in the modeling (Freedman, 2009).
Like previously said, linear regression is used for two types of situations, find-
ing out if independent variables do a good job in predicting dependable variables
and which variables are important predictors for predicting the dependable vari-
ables1. The simplest form of the regression equation can be defined with the
following equation:
Y = β0 + β1X1 + β2X2 + ...+ βnXn
In the previous equation each variable means the following:
Y → Characteristic of interest that we want to predict;
X0,...,n → Molecular Descriptor;
β0,...,n → Weight of each molecular descriptor;
1https://www.statisticssolutions.com/what-is-linear-regression/, last acceded on 31 May
2019
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2.3.2 Non-Linear Models
Nonlinear models allow the adjustment of more complex relationships than linear
or linearizable ones, between the dependent and independent variables, which in
this case are the molecular fingerprints and the biological activity of molecules. In
many cases, such models have their specific functional form for the problem being
treated, because unlike a linear model, non-linear ones don’t have a standard
form. Non-linear models are characterized by the fact that the prediction equation
depends non-linearly on one or more unknown parameters.
A non-linear regression models has the following form:
Yi = f(xi, θ) + i, i = 1, ..., n (2.4)
The Yi are responses, f is a known function of the co-variate vector of predictor
variables xi = (x1,...,xx)T and the parameter vector θ= (θ1,...,xθp)T, and εi are
random errors. The εi are usually assumed to be uncorrelated with mean zero
and constant variance (Smyth, 2002).
Using machine learning there is an extensive library of non-linear algorithms
that can be used to construct statistical models. Among many others, two of
the most used algorithms are Random Forest (RF) and Support Vector Machine
(SVM), due to the advantages they bring to model building (Kausar & Falcao,
2019, 2018; Teixeira et al., 2013).
2.3.2.1 Support Vector Machines
Support Vector Machines (SVM) can address classification and regression prob-
lems. Given a train set, containing labeled data, an SVM training algorithm
builds a model that assigns new data to the corresponding label, through the
recognition of subtle patterns. An SVM model is a representation of data as
points in space, mapped in a very high dimensional feature space or hyperplane
so that data of different categories are divided by a clear gap that is as wide as
possible. New data is later mapped into that same space and predicted to belong
to a category based on the side of the gap on which they fall. Support Vector
Regression (SVR) is one of two main categories of SVM, being the other Suppor
Vector Classification (SVC), whose main feature is to minimize the generalized
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error bound associated with model building, improving the overall performance
(Basak & Patranabis, 2007). In non-linear modeling is used the Kernel function.
Two types of kernels could be used in our work: linear and radial basis functional
(RBF). The difference between both is that RBF kernels can nonlinearly map
samples into a higher dimensional space and linear cannot. Given the nature of
our problem where the relationship between labels and attributes is nonlinear,
using SVR with RBF kernels is preferred.
2.3.2.2 Random Forests
Random Forests (RF) is an ensemble method for classification and regression
when joined with bootstrapping creates a powerful algorithm to generate ma-
chine learning models. RF is an algorithm that is made out of multiple decision
trees, a forest, and each decision tree is made by bootstrapping. Bootstrapping
(Efron, 1979) is a statistical re-sampling technique that involves random sam-
pling of a dataset with replacement. It is often used as a means of quantifying
the uncertainty associated with a machine learning model. In other words, RF
creates decision trees using bootstrapping, being each tree constructed indepen-
dently of previous trees using a different bootstrap sample of data, that work
over a random subset of the data set, selecting it arbitrarily at each node, been
each one chosen by their ability to divide the sample, building a large collection
of correlated trees.
After several independent weak trees (forest) have been created, the RF al-
gorithm uses a consensus voting process to combine the independent forecasts
generated through the weak trees to generate a model that can make optimized
predictions more robustly (Hastie, 2008; Teixeira et al., 2013). The generalization
of this method depends on the strength of the individual trees in the forest and
the correlation between them. In terms of prediction accuracy is one of the top
performs, that provide unique features for QSAR models building. Among them,
one of the most important that this ML algorithm can measure descriptor impor-
tance as well as the similarity between molecules (Genuer et al., 2010; Svetnik
et al., 2003).
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An RF is made up of several parameters, and in this work, the "maximum
depth" parameter (max_depth) had a higher relevance compared to the others,
that were left with the "default" values (Teixeira et al., 2013). Max_depth rep-
resents the depth of each tree in the forest. The deeper the tree, the more splits
it has and it captures more information about the data.
2.3.3 Workflows
The use of QSAR models for the construction of predictive models of molecules
with pharmacological properties of interest is not new. There is a huge range in
the example literature where QSAR methodologies are implemented to accom-
plish this task.
A large portion of the literature is focused on the development and implemen-
tation of a pipeline for a specific target, obtaining good models for it (Martins
et al., 2012). There are works, however, where the aim is to compare the effect of
using different parameters within a small set of targets (Kausar & Falcao, 2019,
2018), aiming to improve the performance of the approach used to build better
and more robust fitness models (Teixeira et al., 2013). Others try to simplify and
automate the process of building QSAR models by allowing the use of QSAR
techniques by the scientific community that has little programming knowledge
(Cox et al., 2013; Dixon et al., 2013).
However, these approaches have something in common. If one tried to modu-
late a large set of targets, as is the case under study, these methodologies would
not be the most appropriate to do so. This is because they take a long time to
model a problem, in other words, these approaches involve a very large compu-
tational cost for large data sets (Kausar & Falcao, 2019).
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Chapter 3
Data and Methods
3.1 Data
3.1.1 Data description
The datasets used in the study comes from the database of the project MIMED
(Abrantes, 2014). A pipeline was developed to fetch molecules with therapeuti-
cally potential from online repositories, namely ChEMBL (Gaulton et al., 2017),
and gathering them in a database where users could download the molecules to
data sets. Data undergo multiple steps to be used, such as the manipulation
of the raw information retrieved from the databases to produce data containing
results to be used in the future (Abrantes, 2014). From this work, 500 datasets
containing information about different chemical tests and activity measures were
extracted. As shown below in table 3.1 the data sets can be divided into 3 big
assay groups A, B and F, each meaning respectively ADME (Absorption, Dis-
tribution, Metabolism, and Excretion), Binding and Functional Assays. Inside
each group, it’s found different activity measures: IC50, EC50, Potency, Ki, Kd,
Inhibition, AC50, RBA, and Activity:
• EC50: Half Maximal inhibitory concentration indicates the value required
for a given substance to inhibit a given biological function.
• IC50: Half Maximal effective concentration represents the concentration
required of a given compound to obtain 50% of the maximum effective
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effect.
• Ki: The inhibitor constant, Ki, is an indication of how potent an inhibitor
is; it is the concentration required to produce half-maximum inhibition.
• Kd: Binding affinity is typically measured and reported by the equilib-
rium dissociation constant (KD), which is used to evaluate and rank or-
der strengths of biomolecular interactions. The smaller the KD value, the
greater the binding affinity of the ligand for its target.
• Potency: Concentration required to elicit a specific response.
• Inhibition: Is the inhibition % under the assay conditions
• AC50: Concentration required for 50% activity;
• RBA: Relative binding affinity;
• Activity: Captures a range of non-standard activities described in refer-
ences;
Activity
Type
A B F Total
IC50 5 191 15 221
EC50 0 4 12 16
Potency 3 0 10 13
Ki 0 93 26 119
Kd 0 2 0 2
Inhibition 5 80 0 85
AC50 0 1 1 2
RBA 0 1 0 1
Activity 1 0 0 1
Total 14 372 64 450
Table 3.1: Different types of data set used in the study.
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3.1.2 Data cleaning
From MIMED Project’s database, 500 data sets were extracted to be used and
worked through all the workflow delimited at the beginning of the project. The
retrieved information about the targets is far from being normalized, due to assay
groups being different as well as the type of activity that each data set measures
and how it does it. In a simple way, the data sets needed to be normalized due to
their nature. This normalization occurs in two steps. The first step is to iterate
over all data sets searching for missing or duplicate data inside them. The missing
data would incapacitate our script from working and the duplicate would only
over-fit the models not adding variety to them, making the models built with
little robustness. When these criteria are met, the line in question is eliminated
from the data set and the next in succession is tested for the same problems. This
process was repeated through all lines inside the data set and after it through all
data sets. Doing this results in the shortening of all data sets, mostly as a result
of deleting lines that had incomplete or missing information about the molecules.
After the process is completed, another step is activated to create a new data
set file, SAR (Structure-Activity Relationship) file, containing only the necessary
information to make models.
A SAR file has 3 columns, each one containing one type of data. The first one
has the ChEMBL ID used to identify a molecule as well as it’s properties, the
second has the activity values for the molecule and the third column possesses
the SMILES format set for retrieving the molecular structure of the molecule.
With this information, QSAR models can be built.
The process resulted in 500 new SAR files containing only the necessary in-
formation from our 500 data sets. Before the cleaning process, all information
gathered in the 500 data sets had a total size of 122 megabytes being reduced,
after cleaning, to a total size of 62 megabytes.
3.1.3 Data Treatment
Following the previous reasoning, all the data used in the study had to undergo
a treatment to be used. The objective of normalizing data is to reduce redun-
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dancy, improve data integrity and facilitate data analyzing. This is done using
an algorithm that processes information contained in our SAR file.
The first step in the process was to find missing data and duplicates of already
existing data in our data and eliminate it. Doing so the data redundancy is
reduced as well as missing information in some of the rows in the data sets,
meaning a cleaner and simpler file to be handled to the model building algorithm,
making the data set better to be worked with. After the first step, there could
be two options, the first one is the case where the data is already normalized and
ready to be worked, simply handled to the script. The second case, and more
common, is where data needs to suffer a transformation through a logarithmic
function (figure 3.3). In the current study case, the information contained on the
data sets wasn’t normalized, so the logarithmic function needs to be applied to
all the 500 data sets in the study.
The way this block of code works is simple. It checks row by row, each line
being a ligand of study, for its activity value, verifying the current quantity unit in
which the activity was recorded. The activity was recorded using different units,
nM, µM, mM, and percentage. Most of the data were registered using nM. Due
to this and the need to normalize all recorded activities, all units that were not
in nM were converted to this except for the recorded activities as a percentage
(3.1).
µM ∗ 1, 000 = nM
mM ∗ 1, 000, 000 = nM
Figure 3.1: Transformation of the units of the activity values.
For the activity to be used by the main algorithm to build models, its values
had to be between 0 and 1. If the value registered on the activity was a percentage,
only a simple division by 100 was needed to have the new value for the normalized
activity (3.2).
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New_Activity =
Activity
100
Figure 3.2: Operation used to normalize activity values that were in percentage.
The rest of the values, who undergo a unit transformation, most now be in
nM, meaning that the logarithm equation can be used to normalize the values,
fitting them in a range between 0 and 1. This transformation can occur in three
different ways:
• In the case of the activity < 1, the new activity (spAct) registered will be
1 meaning that the quantity needed for the ligand, referenced in the row,
to stimulate/inhibit is a target is very low;
• In the case of the activity > 10000, the new activity will be 0 being the
logic equal to the previous point but in reverse, it’s needed a great quantity
of the ligand to stimulate/inhibit its target;
• In the case of the values of the activity is between 0 and 10000 nM, which
is the majority of the cases, the logarithmic function is applied to retrieve
a value between the range of 0 and 1. The scale follows the previous logic,
values near to 1 mean less quantity needed and values closer to 0 means
more quantity needed.
New_Activity = spAct =
4− log10(Activity)
4
Figure 3.3: Logarithmic equation used to normalize activity values.
With the activity normalized, the SAR files are now fully operational to be
used by the algorithm to build QSAR models.
3.2 Methods
This section will be described what software was used to perform the modeling
as well as all the methods applied to obtain the results.
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3.2.1 QSAR model Fitting
QSAR Models can be made using different approaches as previously stated. The
objective of finding the best set of parameters capable of building the best model
for a high number of targets isn’t an easy task. Choosing the ideal bit num-
ber (128, 256, 512, 1024 or 2048), the fitting molecular descriptor and the best
machine learning algorithm are some of the main concerns in terms of QSAR
modeling.
Making QSAR models can be divided into three parts: calculation of molec-
ular descriptors and partition of the data; build of the first models and selection
of the "best" one; validation of the latest with the IVS set. To build a QSAR
model it’s necessary to follow the order described above or otherwise, the models
resulting from this process will not be accurate enough to predict any chemical
property. The developed algorithm works through layers of iterations. It goes
by data sets, radius and finally bit numbers. Each iteration it fetches a different
dataset, previously treated and transformed in a SAR file, selects a radius, a bit
number and goes through the process described above, only changing to a differ-
ent dataset after going through all the bits and radius combinations, repeating it
all over again for all the datasets.
3.2.1.1 Data partition and fingerprints calculation
To do the first part, calculating the Morgan Fingerprints and partition of the
data, the information inside the data sets needs to be extracted to be worked.
This information will originate two variables, one with all the activities from the
ligands and the other with the correspondent Morgan fingerprints. The Morgan
fingerprints are calculated through a function when given the SMILES string of
the ligand. Both variables are going to be divided thus creating two new sets of
data, the Train set, and the Independent Validation Set (IVS), having 75% and
25% of all data correspondingly. The Train set will be used on the second step,
to train our models, and the IVS set will be used on the third and final step to
test and validate the model with the best parameters.
The objective of splitting data into training and testing sets is to maximize the
best learning result and the best validation for the model. More data is allocated
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to the training set because if the model doesn’t learn it can’t predict. Given the
nature of the splitting, random split of the data, it’s hard to reproduce directly
the results obtained for both the train and the test stages.
3.2.1.2 N-Fold Cross Validation
To overcome this problem, the N-fold cross-validation method is used. Taking
the Train set, containing 75% of the data, it’s divided into "N" observations/par-
titions. From this "N" folds, one fold out of these "N" folds is chosen as testing
data set (test fold) while the rest "N-1" is used for training the model (training
folds), equal to the partition of the data in the initial step. Training sets are given
to the model to learn from them. Then the test set is presented to the model,
generating two statistical variables, Root-Mean-Square Error (RMSE) and Per-
centage of variance explained (PVE), that will be used to evaluate the fitness of
the models. This procedure is repeated "N" times, each time selecting a different
fold for the test set and the other folds (N-1) as training sets. Consequently,
"N" different RMSE and PVE are produced from the procedure. With these, a
mean is calculated to describe the overall results, higher the "N" the smaller the
variance, of the learning capability of the model given the original train set (Koul
et al., 2018).
The objective of N-fold Cross Validation is to forecast how the models origi-
nated in this step will perform when exposed to the IVS, previewing which one
will have the best fitness in the later stage of the process. This is done using
two statistical variables RMSE and PVE. Given the values presented by them,
the models can be evaluated in terms of learning and predicting. The criteria for
choosing the best model is to sort all models by the lowest RMSE and the highest
PVE.
3.2.1.3 Model Building
The models are made using 2 different machine learning (ML) algorithms, Ran-
dom Forests (RF) and Support Vector Machine (SVM).
For RF three versions are tested, where what changes is the "maximum depth"
parameter. In these approaches, three different values for maximum depth will
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be used: 2,3 and None. The first two are used to obtain results and thus in-
formation that when increased the maximum depth better results are obtained,
while the "true value" for this parameter is going to be "None", meaning that
the algorithm won’t have any restriction regarding the depths of each tree in the
forest (Landrum, 2019)1.
Combining machine learning algorithms with the N-Fold Cross-Validation
technique originates multiple models. Of these, only the best is returned to
be validated by IVS. The choice is made taking into account the RMSE and PVE
values of each model, these values are compared by model, where the model with
better fitness is chosen as the best model to model the problem in question.
3.2.1.4 Model Validation
Afterward, the model presenting the best combination of RMSE and PVE is
selected to be presented to the IVS. It’s worth noting that by radius is chosen,
20 different models are built, but only 1 is selected to be validated by the IVS.
It’s also to be noted that the results of the IVS are always worst than the Train
set, since the model train with the Train set and when given the IVS, the data
was never seen before during the training period. During this procedure all
information about all models is being saved in two different CSV files to be
analyzed at the end of it, to find the best set of parameters to make QSAR
models. One CSV file will be saving all information about the models build in
the N-fold cross-validation and the other file will only contain the information
about the best model build for each SAR file.
3.2.2 Model Ranking
To get a more in-depth view of the results, a statistical test called Friedman
ranked test was performed (Hollander et al., 2015). This test is a non-parametric
statistical test, or by other words is a test that used data that doesn’t fit a well-
understood distribution, that allows groupings of statistically indistinct treat-
ments under the same grouping, meaning it captures differences between groups.
1https://scikit-learn.org/stable/modules/generated/sklearn.ensemble.RandomForestClassifier.html,
last acceded on 24 June 2019
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In the current work, the modeling approaches correspond to a treatment which
is evaluated by its results for different data sets. Each model is ranked between
the pool of models according to their RMSE scores. Having a lower rank means
having a better performance and a higher rank means the worst performance.
The Friedman test is then applied to understand if the different treatments are
statistically different from each other to be considered better or worst (Hollander
et al., 2015; Kausar & Falcao, 2019). The process begins with the definition of
two hypotheses to be proved:
• H0: There isn’t differences between "K" methodologies;
• H1: There is differences between "K" methodologies;
Being "K" the number of methodologies tested.
After it, the alpha number is selected, being alpha the probability of H0 being
rejected, and the degrees of freedom calculated from a simple equation (k-1).
Both variables are needed to find the value "X" for Chi-Square in the Chi-Square
distribution table, from which the decision rule is made. This rule says that if the
value calculated for Chi-Square is greater than "X" the null hypothesis is rejected
and vice-versa. With this, the following equation 3.1 to calculate Chi-Square can
be applied to find the exact value for Chi-Square for finding if the null hypothesis
is rejected or not.
χ2 =
12
nk(k − 1)
∑
R2 − 3n(k + 1) (3.1)
In this work, "n" is the number of data sets used, "k" the number of different
methodologies used and "R" is the sum of the rankings of the models.
In this case of study the treatments are the difference parameters, for example
the set ML algorithm = SVR | radius = 2 | bits = 512 is one treatment and ML
algorithm = SVR | radius = 3 | bits = 1024 is another. With this test ranking, the
different sets of parameters for the dataset being modeled are possible, allowing
to understand the differences between the treatments with a post hoc analysis.
The purpose of performing this test is to confirm if the conclusion made by
analyzing both RMSE and PVE of the models, about what is the best approach
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to build QSAR models does or doesn’t have some statistical significance to be
affirmed as the best set.
3.2.3 Modeling with Feature Selection
Even though data has been cleaned and redundant information deleted most of
the time models are build with more variables than needed causing poor gen-
eralization of the information. The problem of selecting the minimal subset of
descriptors/variables that can predict a certain pharmacology property with good
performance, efficiency and in a robust way, can be solved using the technique
of feature selection (Teixeira et al., 2013). Using N-fold cross-validation and the
ML algorithm random forest, the importance score of each variable is calculated
to find variables highly related with the target (Genuer et al., 2010), and sorted
by the most relevant variables first and the less important ones last, through
variable importance threshold. After this step, the variables are feed, step-wise,
to an SVR model following the rank order (Genuer et al., 2008).
3.2.4 Software
The main software used on this project was Python1. Python is an easy to learn
language, full of packages and modules that helps interpret many situations and
provides a lot of help when it comes to modeling data sets and analyzes the data
statistically afterwords.
When it comes to modules used in the work, the main one is Anaconda2.
Anaconda is a free and open-source distribution for both Python and R3 with
the purpose of doing scientific computing when it comes to deploying AI and
machine learning. To complement this module, a library was added named SciKit-
Learn4, bringing with it a large selection of modules. From SKLearn, a module
for the partitioning of the data set in the training set and the IVS, a module
for calculating RMSE and PVE, and two modules for calling machine learning
algorithms were used in the development of this work.
1https://www.python.org/doc/essays/blurb/, last acceded on 6 June 2019
2https://www.anaconda.com/what-is-anaconda/, last acceded 6 June 2019
3https://www.r-project.org/, last acceded on 6 June 2019
4https://scikit-learn.org/stable/, last acceded 6 June of 2019
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Was also used RDKIT1 which is an open-source toolkit for cheminformatics
that as the power of processing the data inside of the datasets gives us the ability
to work it. RDKIT has the power of calculating molecular descriptors, reading
sets of molecules, calculate substructure of molecules, write sets of molecules
between many other functionalities.
Lastly, KNIME (Berthold et al., 2007) was used to build QSAR modeling
using a different pipeline than the one used in this work. KNIME is a free and
open-source data analytics, with the ability of integrate various components for
machine learning and data mining through its modular data pipelining concept.
By using it, its possible to generate results in a very efficient way through an
automated pipeline.
1https://www.rdkit.org/docs/Overview.html, last acceded 6 June 2019
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Chapter 4
Results
4.1 Parameterization of QSAR models
The originated models are evaluated according to a set of criteria, that when it
fails to satisfy these criteria, it means that the model has lower or no prevision
power. During the firsts runs of the script, many data sets kept giving problems
due to their nature, meaning that they are a difficult problem to model and,
therefore given this problem and the incapability of solving it, those 50 data sets
were withdrawn from the poll of data sets. Doing this resulted in a total of 450
data sets for further work, with a total size of 52 Mb (table 4.1).
Assay
Group
Number of
Data sets
Percentage
A 14 3
F 64 14
B 372 83
Total 450 100
Table 4.1: Data set differentiation by test group.
With the new data sets normalized, tests were ready to be conducted by the
algorithm, who is now able to run and originate forecasting models, that will be
analyzed and compared between themselves. The algorithm has the configuration
to run and build models within the range of all possible combinations of radius
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of Morgan Fingerprints (2 and 3), number of bits (128, 256, 512, 1024 and 2048)
and machine learning algorithms (Support Vector Regression, Random Forest
with max. depth = 2, Random Forest with maximum depth = 3 and Random
Forest without any maximum depth (= NONE)). The number of models builds
by type can be seen in table 4.2.
Types Models Datasets
IC50 8440 211
EC50 640 16
Potency 520 13
Ki 4760 119
KD 80 2
Inhibition 3400 85
AC50 80 2
RBA 40 1
Activity 40 1
Total 18000 450
Table 4.2: Number of models made from 450 datasets.
The combination of all parameters resulted in 40 models created by data set.
To find out the best parameterization to use for the creation of models for a big
set of problems, the median for the RMSE and the PVE was calculated from the
18000 models originated from each methodology. The results of the combination
can be seen in the following tables.
In table 4.3 the results correspond to an overview aspect of our data per
assay group, giving us the perception of the quality of our data and what type of
predictive models are being made by the algorithm.
36
4.1 Parameterization of QSAR models
Assay
Group
ECFP4 ECFP6
Median
RMSE Train
Median
PVE Train
Median
RMSE Train
Median
PVE Train
A 0.163 0.219 0.165 0.188
B 0.209 0.414 0.219 0.357
F 0.16 0.306 0.164 0.259
Table 4.3: Median values of training RMSE and PVE per assay group.
Generally for each assay group, in Morgan Fingerprints radius = 2 (ECFP4)
methodologies models tend to be better in both RMSE and PVE when compared
to methodologies where Morgan Fingerprints are = 3 radius (ECFP6). Between
each assay group through the analysis of the obtained values, the best models
come from group B followed by group F and finally group A.
In table 4.4 it’s notable the contribution of each machine learning algorithm
for the making of the prediction models and which are better.
Machine
Learning
Algorithm
ECFP4 ECFP6
Median
RMSE Train
Median
PVE Train
Median
RMSE Train
Median
PVE Train
RF MD 2 0.2301 0.2724 0.2309 0.2682
RF MD 3 0.2151 0.3595 0.2157 0.3526
RF MD NONE 0.1769 0.5702 0.1796 0.5572
SVR 0.2062 0.4286 0.2316 0.2709
Table 4.4: Median values of training RMSE and PVE per machine learning algo-
rithm.
The first notable thing about these results is the significant improvement in
models created with RF as forest depth increases. When comparing SVR results
and RF, the methodology that uses RF without depth limitation is the one that
produces the best models with both ECFP4 and ECFP6.
All the models created with RF with maximum depth 2 and 3 were done with
two purposes, of comparison with the model created with SVM and RF with a
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maximum depth of none and to affirm that when RF models are built without
limitation of the forest of trees, models have a better prediction power with lower
error. Because of this only the results of the Random Forest without maximum
depth and Support Vector Regression have been taken into account for the rest
of the work leaving the other two aside.
Random Forest
MD = NONE
ECFP4 ECFP6
Median
RMSE Train
Median
PVE Train
Median
RMSE Train
Median
PVE Train
128 0.1837 0.5421 0.1892 0.5218
256 0.1788 0.5668 0.1816 0.5485
512 0.1758 0.5753 0.1781 0.5645
1024 0.1749 0.5814 0.175 0.5771
2048 0.1726 0.5891 0.1736 0.5795
Table 4.5: Median of training RMSE and PVE for Random Forest MD = None
per number of bits.
Looking at the overall results it can be seen an increase in performance as
the number of bits goes from 128 up to 2048, also models made with ECFP4
seem to have a little better performance than models made with ECFP6, as seen
before. Between the number of bits 1024 and 2048 both RMSE and PVE, for
both ECFP4 and ECFP6, are almost identical being the models made by 2048
slightly better (table 4.5).
Support
Vector Regression
ECFP4 ECFP6
Median
RMSE Train
Median
PVE Train
Median
RMSE Train
Median
PVE Train
128 0.1941 0.4841 0.2074 0.4238
256 0.2026 0.4524 0.2256 0.3282
512 0.209 0.4271 0.2371 0.2662
1024 0.2121 0.4021 0.2419 0.2372
2048 0.2139 0.3969 0.2447 0.2232
Table 4.6: Median of training RMSE and PVE for Support Vector Regression per
number of bits.
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For the models made with SVR, there is also a difference in the results as the
number of bits rises. In contrary to random forest models, as the number of bits
rises the results decreases, being the best models the ones made with 128 bits
with ECFP4 (table 4.6).
Analyzing the best models made out of the 450 data sets, from the 900 QSAR
models (450 for each ECFP) made, 898 were build using RF without maximum
depth. In terms of ECFP, fingerprints made with radius = 2 have slightly better
results compared with models made with radius = 3. The same can be said
for the bit numbers, models made with 2048 bits have a little bit better results
compared with models made with both 512 and 1024 bits (table 4.7).
Bit
Number
ECFP4 ECFP6
Median
RMSE Train
Median
PVE Train
Median
RMSE IVS
Median
PVE IVS
Median
RMSE Train
Median
PVE Train
Median
RMSE IVS
Median
PVE IVS
512 0.1765 0.5839 0.1832 0.5459 0.1781 0.5714 0.1843 0.5575
1024 0.1631 0.6299 0.1682 0.6076 0.1724 0.6082 0.1752 0.5969
2048 0.1682 0.6413 0.1711 0.6366 0.1698 0.6243 0.1706 0.6132
Table 4.7: Comparison of the results of the best models.
To complete the results presented in the tables, three plots were performed
through the 40 tested approaches, comparing the average RMSE obtained by each
one.
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Figure 4.1: Distribution of the mean RMSE for all 40 approaches.
The above density plot (figure 4.1) compares the mean RMSE values for all
40 approaches used and how it is distributed over its range of values. Notable
on the plot is the existence of two large groups. The first group (leftmost),
shows a central tendency (mean RMSE) close to 0.17 while the second group
(rightmost), has a central tendency between 0.21 and 0.22. This indicates that
there is undoubtedly a group of methodologies which in comparison with the
others behave better.
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Figure 4.2: Comparison of the distribution of the RMSE for ranks 1, 10, 20 and
40.
To complement the density plot of figure 4.2, a new plot comparing the dis-
tribution of RMSE values for 4 different methodologies was made. Following the
logic mentioned above, the difference in distributions between the 4 approaches is
visible. In agreement with what was seen in table 4.7 the best models are made
with RF without maximum depth using ECFP4 and 2048 bits and the worst
models were made with SVR using ECFP6 and 2048 bits.
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Figure 4.3: Friedman ranking test plot.
To complete the latter information a Friedman plot was made 4.3 where it
clearly shows the difference in performance between the 40 approaches used. In
the figure, each approach is inserted into a group (represented by a letter) depend-
ing on its performance. Approaches within the same group have no statistically
significant differences in their performance whereas approaches in different groups
have.
In general, it’s possible to group the approaches by the type of machine
learning algorithm used, with special attention to RF without maximum depth
(RF_0). Through the analysis of the graph, it is observed that all 10 approaches
using this RF_0 are present in the top 10 methodologies that have the best per-
forming, meaning random forest without depth limitations probably is the best
machine learning algorithm to use to build QSAR models.
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4.2 Modeling using Feature Selection
With the best set of parameters selected for modeling our data sets the next step
was trying to grab these criteria and optimize the process as well as the final
result of these. The method used relies heavily upon the weight of each variable
in the model. The importance score of each variable is calculated by the RF
algorithm and used later by the developed code to create a new model with the
help of the SVR algorithm. Doing a control test with only the RF algorithm to
create the model resulted in a median for RMSE of 0.1695 and PVE of 0.6101. In
the procedure of calculating the importance score of each variable of the model,
using only the ones that add something new to the model and creating the model
with SVR the median for RMSE was 0.1712 and PVE was 0.5825.
Mean Median
NVAR 110 110
RMSE
before FS
0.1703 0.1695
PVE
before FS
0.5661 0.6101
RMSE
after FS
0.1749 0.1712
PVE
after FS
0.5282 0.5825
Table 4.8: RMSE and PVE before and after using feature selection.
When comparing the values obtained after validation of models created with
feature selection (table 4.8 and models created without this technique table 4.7), it
is concluded that there are no differences in performance between the approaches.
This is also showed in table 4.8 when comparing the values for RMSE and PVE
before and after doing the feature selection. Unfortunately, the results obtained
weren’t the ones that we expected. Before calculating the importance of the
variables 5-fold cross-validation was done with random forest and a model was
trained with the training set for the 450 targets, obtaining a median for the RMSE
of 0.1695 and a mean for the PVE of 0.6101. After doing the feature selection
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and build the final model for the same targets, the median was calculated and
was obtained an RMSE of 0.1712 and a PVE of 0.5825. Analyzing these results
and comparing them, there is an increase of approximately 1% for the RMSE
after feature selection and a decrease of approximately 4% for PVE after feature
selection.
However, given the logic of the feature selection technique, the number of vari-
ables was reduced compared to other methodologies because many of the variables
used in construction of the model didn’t add new information to it during the
learning phase. Since fewer variables were used to construct models, they become
more statistically robust than models created without feature selection as well as
tend to generalize better the problems.
Figure 4.4: Correlation between the number of variables and RMSE after feature
selection.
The analysis of scatter plot 4.4, shows that models constructed using a number
of variables between 60 and 500, the mean value for RMSE never exceeds 0.19
and the best result is obtained for the number of variables = 75, where RMSE
= 0.15 and PVE = 0.59. Note that QSAR models built with more than 150
variables no longer gain prediction power.
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Figure 4.5: Correlation between the values of RMSE before and after feature
selection.
When correlating both RMSE’s the result can be seen in the scatter plot
of figure 4.5. According to the plot it was achieved a high positive correlation
between both statistical variables, RMSE before and after feature selection, along
with all 450 targets. This is also showed by both the trend line of y = 0.8928X
+ 0.0229 and the R2 of 0.7223. This indicates that almost all 450 trained models
have positive results in terms of RMSE, except for 6 of them that don’t correlate
at all. The relationship between both RMSE’s leads to the conclusion that QSAR
models can only gain by reducing the number of variables, making them more
robust and better generalizing the problems.
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Figure 4.6: Correlation between the values of PVE before and after feature se-
lection.
The figure 4.6 which is the scatter plot for PVEs, its observed that the dots
are a lot more dispersed in graphic. This indicates that the the correlation is
positive but low. This can be due to the fact of the nature of PVE. Looking to
the correlation of the both PVE’s for all 450 targets, the result is a trend line of
y = 1.0177X + 0.0479 and a R2 of 0.4606.
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Discussion
5.1 Data set handling result
The initial idea was to work with all the 500 datasets that were extracted from
the MIMED database. Unfortunately, it wasn’t feasible. At first glance, the idea
was to eliminate the duplicates and try to fill missing information by searching it
on the online repositories. Almost all the data sets had missing activity values,
quantity and even in some cases the SMILES ID. In an initial effort to keep all
data inside the data sets search in the ChemBL database were made molecule by
molecule but the amount of data missing was very. Given this problem, the deci-
sion to eliminate lines with missing information was made, losing a considerable
portion of information per data set.
With this problem solved each data set was processed into a new file form,
SAR (Structure-Activity Relationship) file, having only the necessary information
for the model making, the ID of the molecule, activity between 0 and 1 and the
SMILE ID. After this transformation, a basic test was made to see if the data set
would produce models given us the second hiccup. A threshold for both RMSE
and PVE was set, to guarantee that the QSAR models build were learning and
therefore having prediction power. To achieve this a value of 0.30 for RMSE and
above 0.30 for PVE was needed for each model. In this test 50 models failed
to pass both criteria, meaning that 50 data sets as they were being difficult to
model leaving us with 450 data sets to work with the rest of the project. Of this
450 sets around 83% are from the group B of the assay group, meaning that the
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majority of the information gathered from online repositories is obtained from
binding assays. This is a big bonus for the QSAR modeling due to the nature of
the technique itself, which is ligand-based.
5.2 Parameterization of QSAR models results
All possible combinations of machine learning algorithms, Morgan Fingerprints,
and the number of bits were made and posteriorly analyzed, to find the approach
to make QSAR models for 450 targets.
From this algorithm, 18000 models were made from 450 data sets, meaning
that each data set originates 40 models, being equivalent of having, for each
machine learning algorithm used, 8 models build corresponding to each of the 5
number of bits used and both fingerprints (4 ML algorithm * 5 bits numbers * 2
ECFP = 40 models per data set). The first type of comparison made was between
the 3 assay group to see the firsts differences in the data sets. For this we need to
have in mind the differences in the number of data sets for each group, meaning
that a group with more data sets has a value more close to the real one. The
group A only has 3% of all data sets meaning that the amount of "samples" is far
from the ideal, followed by group F with an amount of 14% and finally group B
with 83% having the majority of the data sets. In terms of RMSE values, the best
overall is group F with approximately 0.16, followed by group A with 0.163 and
finally by group B with 0.209. The values shown tell us that the models made
by group F have a better chance to predict what is reality. However like said
above the number of data sets used in the making of the models has a statistical
weight, meaning that probably the group B results are the ones closer to the
actual RMSE and PVE values for the given group.
Looking at the results in terms of which algorithm performed better, Random
Forest with maximum depth none has a clear lead in both parameters. But does
it differ when it comes to a specific configuration of the ML algorithm and number
of bits? Models with Random Forest with maximum depth of 2 and 3 were done
in the first predictive models to have a means of comparison and to confirm that
random forests with deeper trees capture more information about the data when
compared with RF with lower depth. Following this logic, only the results for
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models made with random forest maximum depth none and models made with
support vector regression will be considered.
Grabbing the results for the random forest, when comparing both fingerprints
used, the best one to use is ECFP4 with slightly better performance than models
made with ECFP6. However, it is clear that the bigger the number of bits, using
ECFP4, the better results the model will have, starting at an RMSE of 0.1837
and a PVE of 0.5421 for 128 bits down to an RMSE of 0.1726 and a PVE of 0.5891
when using 2048 bits. This is due to the nature of the algorithm itself combined
with the function of the number of bits, which is the higher the number the more
information is retained which means, more the model learns and closer it gets to
the reality when predicting results. The same cannot be said for SVR results.
The bigger the number of bits, using ECFP4, the worst it the performance of
models, going from an RMSE of 0.1941 and a PVE of 0.4841 when using 128
bits, to an RMSE of 0.2139 and a PVE of 0.3969 when using 2048 bits. The
reason for this may be due to the wrong parameterization of the algorithm or the
nature of the algorithm implementation.
Another factor that was taken into account while parameterizing the models
was the size of the data sets.
Figure 5.1: Relation between size of the data set with the value of RMSE IVS
using ECFP4.
49
5. DISCUSSION
Figure 5.2: Relation between size of the data set with the value of PVE IVS using
ECFP4.
Analyses were made to understand what was the impact that the size of the
data set could have on the results of training a model (Kausar & Falcao, 2018).
As shown in both figure 5.1 and 5.2 at lower sizes the results tend to be non-linear
scale between 0.05 up to 0.37 for RMSE and 0.02 to 0.87 for PVE, but as the
size of the data grow the results stabilize as shown in the figures. Although this
is true, most of our data is centered in size of <2000 molecules and because of
that results can vary one to another.
With the previous analysis and taking into account all the methodologies
used in this work, the best approach for making QSAR models for a large set of
problems is using Random Forest without maximum depth, coupled to ECFP4
and number of bits = 2048.
5.3 Modeling using Feacture Selection results
Based on the previous selection of parameters, a method of selection of the most
important variables to build a model was performed for all data sets, with the
idea of reducing the high dimensionality associated with each problem, making
the models more robust and less susceptible to over-fitting.
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5.3.1 Comparison of models with and without feature se-
lection
After performing the feature selection the mean value for RMSE is 0.1749 and
for PVE is 0.5282. When comparing these values with our previous ones, it’s
noticeable the impact of feature selection when looking at the results of models
built based on support vector regression without feature selection. The decrease
in terms of the RMSE is approximately 19% and the increase of the PVE is
approximately 41%. Looking and analyzing this values it is safe to conclude that
alone the support vector regression algorithm alone is not able to build a good
prediction model, but when introduced to feature selection it is able to originate
a model with a minimum subset of important variables, that is faster to train, is
more robust and have a better prediction capability when compared to the later.
In terms of the models build around the random forest when comparing them
versus the models build with feature selection, the results are also positive but
with lower impact. The decrease in terms of the RMSE is approximately 1% and
the increase of the PVE is approximately 11%. Although the results obtained
here aren’t as good as the ones obtained versus support vector regression, it still
adds a slightest boost to the overall fitness of the models build, as well as the
same benefits added to the support vector regression models, a minimum subset
of important variables, faster to training of the models, more robustness and have
a better prediction capability.
RMSE PVE
Random Forest
Models
0.1769 0.5216
SVR
Models
0.2146 0.3448
Feature Selection
Models
0.1749 0.5825
Table 5.1: Results for RMSE and PVE for different approaches.
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5.4 Kausar Pipeline
To compare the results obtained with the chosen methodology (RF_0), 10 ran-
dom data sets were chosen and used to obtain results in the workflow developed
in KNIME as well as in the approach adopted by this work (Kausar & Falcao,
2018). The Kausar method was developed with the help of R’s libraries to en-
hance the methodology and obtain better results. In addition to this, this later
methodology uses the same parameters that the developed method uses except
on the fingerprints, which changes twice, using Morgan Fingerprints (Kausar_1)
and AtomPairs (Kausar_2). The objective in to understand how the developed
methodology performs when compared to another pipeline that generates QSAR
models.
To compare the results obtained by the chosen approach, results were obtained
using a pipeline developed in KNIME. Ten data sets were randomly chosen from
the poll of 450 to build QSAR models. These are used to obtain results in both
the chosen methodology of this work and the KNIME approach. To better un-
derstanding, the following tables and graphics, all data sets names were changed
to the corresponded gene of the ChEMBL ID (table 5.2).
Data Set
Names
Gene Assay Group Activity
Data
Size
Number of
Variable used
CHEMBL1941 HRH2 B IC50 125 30
CHEMBL1827 PDE5A B Ki 118 3
CHEMBL286 REN B IC50 3953 170
CHEMBL2093865 HDAC3 B Inhibition 718 50
CHEMBL340 CYP3A4 A Activity 553 55
CHEMBL210 ADRB2 F EC50 1102 55
CHEMBL1741189 GFER B AC50 1465 170
CHEMBL3687 ALOX12 F Potency 2674 90
CHEMBL4158 FASN F IC50 2060 140
CHEMBL2954 CTSS B IC50 1830 180
Table 5.2: Decoding data set name to the corresponding gene name for all 10
data sets chosen.
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As previously stated the objective of this step is to compare directly the fitness
of models created with the chosen methodology, with the fitness of models created
with another pipeline. To do so, the KNIME pipeline was checked and parameters
changed to ensure that the general workflow of our methodology was respected.
In the RF_0 methodology, chosen in this work, when performing a 5-fold
cross-validation of the random forest algorithm, with Morgan fingerprints (ECFP4)
and 2048 bits, coupled with feature selection using support vector regression
method with the 10 data sets, the median of the RMSE obtained is 0.19 and the
mean of the PVE is 0.48 (Table 5.3).
Gene
Names
RF_0
MF
RMSE PVE
HRH2 0.1283 -0.265
PDE5A 0.2304 0.6369
REN 0.2028 0.6444
HDAC3 0.2801 0.3296
CYP3A4 0.2081 0.6798
ADRB2 0.2034 0.7082
GFER 0.1873 0.043
ALOX12 0.1066 -0.057
FASN 0.0972 0.2386
CTSS 0.1787 0.6698
Mean 0.1823 0.3628
Table 5.3: Results for RMSE and PVE using the first methodology.
In the Kausar methodology (Kausar & Falcao, 2018), the majority of the
parameters used are equal to the RF_0 methodology, the number of bits (2048)
and the feature selection method, to the exception of fingerprints. Two types of
fingerprints were used on the KNIME pipeline, the ECFP4 (Kausar_1), and the
AtomPair fingerprints (Kausar_2). In Kausar_1, when performing a 5-fold cross-
validation of the random forest algorithm, with Morgan fingerprints (ECFP4),
coupled with feature selection using support vector regression method using the
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10 data sets, the median of the RMSE obtained is 0.18 and the mean of the PVE
is 0.52 (Table 5.4). In Kausar_2, when performing 5-fold cross-validation of the
random forest algorithm, with AtomPairs, and coupled with feature selection
using support vector regression method using the 10 data sets, the median of the
RMSE obtained is 0.19 and the mean of the PVE is 0.5 (Table 5.4).
Gene
Names
Kausar Methodology
MF AP
RMSE PVE RMSE PVE
HRH2 0.1464 0.2936 0.1756 -0.9081
PDE5A 0.1560 0.7979 0.2046 0.7149
REN 0.1925 0.6363 0.2111 0.5637
HDAC3 0.2513 0.3204 0.2581 0.2749
CYP3A4 0.2118 0.6631 0.2364 0.6155
ADRB2 0.2291 0.6535 0.2222 0.6580
GFER 0.1690 0.0066 0.1759 0.0045
ALOX12 0.0863 0.0642 0.0744 0.0564
FASN 0.0693 0.4082 0.0674 0.4345
CTSS 0.1818 0.6613 0.1816 0.6485
Mean 0.16936 0.45051 0.18072 0.306261
Table 5.4: Results for RMSE and PVE using the second methodology.
Comparing the results of both approaches, it is noteworthy that 3 of the
10 randomly chosen models are difficult to model because of the PVE values
being obtained. Performing the Friedman ranking test concludes that there are
no significant statistical differences to affirm that one of the three approaches
compared stands out in relation to the others. However, it is noteworthy that
approach 2 using ECFP4 generally gives the best results.
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Figure 5.3: Comparison of 10 data sets constructed using different methodologies
in terms of RMSE.
Figure 5.4: Comparison of 10 data sets constructed using different methodologies
in terms of PVE.
Looking into the graphics there are differences in the results both in RMSE
and PVE (figure 5.3 and figure 5.4). Using the RF_0 methodology, a median
for the results of the 10 data sets was calculated resulting in an RMSE of 0.19
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and a PVE of 0.48. In terms of Kausar methodology developed in KNIME with
Morgan Fingerprints, the median for the RMSE was 0.18 and a PVE of 0.52 were
obtained. As for Kausar_2, the method developed in KNIME using AtomPair,
the median for the RMSE was 0.19 and a PVE of 0.5 were obtained.
Based only on the results of 10 data sets the best way to make predictive
models is to use the methodology developed in KNIME using Morgan Finger-
prints. However, one must have in mind that this method was developed using
different resources and libraries and with a different purpose. When all 3 methods
are analyzed through the Friedman test, it concluded that all 3 do not have any
significant statistical differences between then, meaning that depending on the
purpose of the task one may choose one method over the other, without having
a significant impact when modulating the target.
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Chapter 6
Conclusions
In this work, diverse methodologies involving QSAR modeling, with the support
of the sklearn machine learning algorithm’s library were tested to find the best
one to build models for a large set of problems, to help the molecular research
environment to predict the pharmacology properties of several molecular targets.
Using the information contained in the MIMED project’s database, 500 tar-
gets were extracted from it. The data inside those data sets come from different
laboratory experiments, meaning that their nature is not the same from one to
another. Using the MIMED data sets as a starting point, a script was made
to normalize and fix the missing information inside the targets. As a result of
this action, information was lost in the normalization of the targets as expected,
reducing the size of the data sets up to 49%.
With the data sets normalized the first models could be made. Evaluation
norms were specified to ensure that the models were learning from our data. In
the first rounds of training and testing the predictive models, was concluded that
some targets are very difficult for modeling due to their nature. Because of this
problem the poll was shortened in about 50 data sets coming to a total of 450
data sets.
During this procedure, different approaches represented by the combinations
of machine learning algorithms, fingerprints and number of bits were tested re-
sulting in a lot of data, which after analyzing it, culminating in the best overall
approach to build QSAR models. The best methodology to build predictive
models for a large number of problems is using random forest without maximum
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depth, ECFP4, and 2048 bits. Although the best set of parameters where chosen
it was known that the script could be enhanced to produce better results in terms
of building forecasting models.
Using the technique of feature selection for QSAR, random forests were used to
calculate the best subset of variables using their importance for model training.
Then variables that added more variance to the model were used to build the
final model using support vector regression. The final models build represented
a better performance in RMSE, from 1% up to 19%, and PVE, from 11% up to
41%.
The methodology was then compared to others developed previously. The
methodology chosen to be compared to was developed in KNIME using Java and
R. In terms of time spent modeling the problems, the methodology chosen in this
work is faster compared to the one developed in KNIME, although the final results
in this second methodology appear to have better performance. A Friedman test
was made and statistically speaking there are no significant differences between
then.
In short, through this work, we have established the best approach to build
robust QSAR models in the shortest possible time from a pool of 40 methodolo-
gies.
6.1 Future Work
The chosen of this methodology opens many doors in QSAR modeling. The first
task to be tested with the work developed in this thesis is to proceed with a
functional test of a specific problem. Using the chosen approach, build QSAR
models that after doing virtual screening to select molecules with the potential
to solve a problem, test them in vitro.
The approach chosen, like other, have its flaws. An example of this is the 50
targets that have been set aside. It would be interesting to incorporate new tech-
niques, different machine learning algorithms together with different fingerprints,
as well as improvements to this methodology to encompass more complicated
modeling problems.
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6.1 Future Work
It would also be interesting to see how does this methodology performs com-
paring to other approaches not worked in this thesis such as distance based meth-
ods.
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